Plasma Cell‐Free DNA Genotyping: From an Emerging Concept to a Standard‐of‐Care Tool in Metastatic Non‐Small Cell Lung Cancer

Plasma cell‐free DNA (cfDNA) genotyping is an alternative to tissue genotyping, particularly when tissue specimens are insufficient or unavailable, and provides critical information that can be used to guide treatment decisions in managing patients with non‐small cell lung cancer (NSCLC). In this ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Jhanelle, Thompson, Jeffrey C., Carpenter, Erica L., Elkhouly, Ehab, Aggarwal, Charu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488793/
https://www.ncbi.nlm.nih.gov/pubmed/34216176
http://dx.doi.org/10.1002/onco.13889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488793/
https://www.ncbi.nlm.nih.gov/pubmed/34216176
http://dx.doi.org/10.1002/onco.13889

Ejemplares similares